Correction to Lancet Diabetes Endocrinol 2025; 13: 699–721

IF 41.8 1区医学 Q1 ENDOCRINOLOGY & METABOLISM

The Lancet Diabetes & Endocrinology Pub Date : 2025-09-18 DOI:10.1016/s2213-8587(25)00293-1

引用次数: 0

Abstract

Brandi ML, Pieterman CRC, English KA, et al. Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice. Lancet Diabetes Endocrinol 2025; 13: 699–721—In this Review, the spelling of Camilla Schalin-Jäntti's name was incorrect in the appendix. This correction has been made to the online version as of Sept 18, 2025.

查看原文本刊更多论文

《柳叶刀糖尿病内分泌》2025修订版；13: 699 - 721

Brandi ML, Pieterman CRC, English KA，等。1型多发性内分泌瘤（MEN1）：最佳实践的建议和指南。柳叶刀糖尿病内分泌2025；[03:699 - 721]在这篇评论中，附录中Camilla Schalin-Jäntti的名字拼写不正确。此更正已于2025年9月18日对在线版本进行了修改。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Lancet Diabetes & Endocrinology ENDOCRINOLOGY & METABOLISM-

CiteScore

61.50

自引率

1.60%

发文量

371

期刊介绍： The Lancet Diabetes & Endocrinology, an independent journal with a global perspective and strong clinical focus, features original clinical research, expert reviews, news, and opinion pieces in each monthly issue. Covering topics like diabetes, obesity, nutrition, and more, the journal provides insights into clinical advances and practice-changing research worldwide. It welcomes original research advocating change or shedding light on clinical practice, as well as informative reviews on related topics, especially those with global health importance and relevance to low-income and middle-income countries. The journal publishes various content types, including Articles, Reviews, Comments, Correspondence, Health Policy, and Personal Views, along with Series and Commissions aiming to drive positive change in clinical practice and health policy in diabetes and endocrinology.